Luke Sergott
Stock Analyst at Barclays
(4.48)
# 1,089
Out of 4,649 analysts
748
Total ratings
48.8%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintained: Buy | $260 → $340 | $309.93 | +9.70% | 15 | Aug 10, 2026 | |
| QGEN Qiagen | Maintained: Hold | $38 → $40 | $42.95 | -6.87% | 18 | Aug 7, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $19 → $22 | $18.89 | +16.46% | 43 | Aug 7, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $220 → $300 | $280.05 | +7.12% | 20 | Aug 5, 2026 | |
| WAT Waters | Maintained: Buy | $425 → $460 | $412.17 | +11.60% | 35 | Aug 5, 2026 | |
| CERT Certara | Maintained: Hold | $6.5 → $7.5 | $8.00 | -6.25% | 36 | Aug 5, 2026 | |
| DHR Danaher | Maintained: Buy | $230 | $202.45 | +13.61% | 47 | Aug 4, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,500 → $1,575 | $1,419.02 | +10.99% | 10 | Aug 3, 2026 | |
| ILMN Illumina | Maintained: Sell | $145 → $160 | $190.89 | -16.18% | 50 | Jul 31, 2026 | |
| LH Labcorp Holdings | Maintained: Hold | $290 → $320 | $318.13 | +0.59% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $200 | $157.21 | +27.22% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 → $275 | $236.66 | +16.20% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $22 | $17.41 | +26.36% | 21 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $250 | $234.40 | +6.66% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $625 → $650 | $588.29 | +10.49% | 46 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $349.42 | +14.48% | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $166.83 | -4.09% | 11 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $450 | $578.50 | -22.21% | 10 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $150 | $148.53 | +0.99% | 33 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 → $60 | $57.70 | +3.99% | 18 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $175 | $163.15 | +7.26% | 41 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 | $116.84 | -10.13% | 33 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $95 | $118.57 | -19.88% | 40 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $7 → $8 | $13.66 | -41.43% | 44 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $40 | $56.09 | -28.69% | 34 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $1 → $1.5 | $1.15 | +30.43% | 26 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $42 | $6.72 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $279.71 | n/a | 1 | Jan 18, 2023 |
Natera
Aug 10, 2026
Maintained: Buy
Price Target: $260 → $340
Current: $309.93
Upside: +9.70%
Qiagen
Aug 7, 2026
Maintained: Hold
Price Target: $38 → $40
Current: $42.95
Upside: -6.87%
Sotera Health Company
Aug 7, 2026
Maintained: Buy
Price Target: $19 → $22
Current: $18.89
Upside: +16.46%
Charles River Laboratories International
Aug 5, 2026
Maintained: Buy
Price Target: $220 → $300
Current: $280.05
Upside: +7.12%
Waters
Aug 5, 2026
Maintained: Buy
Price Target: $425 → $460
Current: $412.17
Upside: +11.60%
Certara
Aug 5, 2026
Maintained: Hold
Price Target: $6.5 → $7.5
Current: $8.00
Upside: -6.25%
Danaher
Aug 4, 2026
Maintained: Buy
Price Target: $230
Current: $202.45
Upside: +13.61%
Mettler-Toledo International
Aug 3, 2026
Maintained: Buy
Price Target: $1,500 → $1,575
Current: $1,419.02
Upside: +10.99%
Illumina
Jul 31, 2026
Maintained: Sell
Price Target: $145 → $160
Current: $190.89
Upside: -16.18%
Labcorp Holdings
Jul 31, 2026
Maintained: Hold
Price Target: $290 → $320
Current: $318.13
Upside: +0.59%
Jul 31, 2026
Maintained: Buy
Price Target: $150 → $200
Current: $157.21
Upside: +27.22%
Jul 29, 2026
Maintained: Buy
Price Target: $210 → $275
Current: $236.66
Upside: +16.20%
Jul 29, 2026
Maintained: Hold
Price Target: $18 → $22
Current: $17.41
Upside: +26.36%
Jul 24, 2026
Maintained: Buy
Price Target: $230 → $250
Current: $234.40
Upside: +6.66%
Jul 24, 2026
Maintained: Buy
Price Target: $625 → $650
Current: $588.29
Upside: +10.49%
Jul 24, 2026
Maintained: Buy
Price Target: $400
Current: $349.42
Upside: +14.48%
Jul 23, 2026
Maintained: Buy
Price Target: $160
Current: $166.83
Upside: -4.09%
Jul 23, 2026
Maintained: Hold
Price Target: $450
Current: $578.50
Upside: -22.21%
Jun 24, 2026
Rated: Buy
Price Target: $145 → $150
Current: $148.53
Upside: +0.99%
Jun 24, 2026
Rated: Buy
Price Target: $53 → $60
Current: $57.70
Upside: +3.99%
Jun 24, 2026
Maintained: Hold
Price Target: $150 → $175
Current: $163.15
Upside: +7.26%
Jun 24, 2026
Maintained: Hold
Price Target: $105
Current: $116.84
Upside: -10.13%
Jun 24, 2026
Rated: Buy
Price Target: $65 → $95
Current: $118.57
Upside: -19.88%
Jun 24, 2026
Rated: Sell
Price Target: $7 → $8
Current: $13.66
Upside: -41.43%
Jun 24, 2026
Rated: Buy
Price Target: $30 → $40
Current: $56.09
Upside: -28.69%
May 11, 2026
Rated: Sell
Price Target: $1 → $1.5
Current: $1.15
Upside: +30.43%
Jun 12, 2023
Maintained: Hold
Price Target: $35 → $42
Current: $6.72
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $279.71
Upside: n/a